Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 836.64 million compared to CNY 686.91 million a year ago. Revenue was CNY 837.11 million compared to CNY 688.17 million a year ago.

Net income was CNY 110.11 million compared to CNY 74.65 million a year ago. Basic earnings per share from continuing operations was CNY 0.3201 compared to CNY 0.2232 a year ago. Diluted earnings per share from continuing operations was CNY 0.3201 compared to CNY 0.2232 a year ago.